Cost benefit analysis of two policy options for cannabis: Status quo and legalisation

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Shanahan, Marian ^a   Ritter, Alison ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; MEDICAL CANNABIS;

ARTICLE; AUSTRALIA; CLASSIFICATION; COST BENEFIT ANALYSIS; COST CONTROL; DRUG LEGISLATION; EDUCATIONAL STATUS; GOVERNMENT REGULATION; HEALTH CARE POLICY; MONTE CARLO METHOD; NET SOCIAL BENEFIT; SENSITIVITY ANALYSIS; SOCIAL ASPECT; SOCIOECONOMICS; WELLBEING; ECONOMICS; HUMAN;

CANNABIS; COST-BENEFIT ANALYSIS; HEALTH POLICY; HUMANS; MEDICAL MARIJUANA; MONTE CARLO METHOD;

EID: 84899670968     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095569     Document Type: Article

References (93)

1. UNODC (2010) World Drug Report 2010. United Nations Publication Sales No. E.10.XI.13. 194 p. Available: http://www.unodc.org/documents/wdr/WDR-2010/ World-Drug-Report-2010-lo-res.pdf∧. Accessed July 2011.
2. European Legal Database on Drugs (2007). European Monitoring Centre for Drugs and Drug Addiction. Available: http://eldd.emcdda.europa.eu/html.cfm/ index5769EN.html.
3. Hughes C, Stevens A (2007) The Effects of Decriminalization of Drug Use in Portugal. The Beckley Foundation Drug Policy Programme. Available: http://www.idpc.net/ php-bin/documents/BFDPP-BP-14-EffectsOfDecriminalisation- EN.pdf.pdf∧.
4. McLaren J, Mattick R (2006) Cannabis in Australia. Use, supply, harms, and responses. Canbera Drug Strategy Branch, Australian Government Department of Health and Ageing.
5. Room R, Fischer B, Hall W, Lenton S, Reuter P (2008) Cannabis Policy: Moving beyond stalemate. Oxford: Beckely Foundation.
6. Englesman E (2003) Cannabis Control: the model of the WHO tobacco control treaty. The International Journal of Drug Policy 14: 217-219.
7. Wodak A, Reinarman C, Cohen P (2002) Cannabis control: costs outweigh the benefits: For. British Medical Journal 324: 105-106.
8. Limb M (2012) Ban on recreational drugs is impeding science, says former government drugs adviser. BMJ 344; doi:10.1136/:bmj.e3936.
9. Miron J (2005) The budgetary implications of Marijuana prohibition. Cambridge, MA: Harvard University. Available: http://www.prohibitioncosts.org/ mironreport.html∧.
10. Wilson J (1991) Drugs and Crime In: Tonry M, Wilson J, editors. Drugs and Crime: Crime and Justice Volume 13: The University of Chicago Books. 574 p.
11. Wilson J (1990) Against the Legalization of Drugs, Commentary 89: 21-28.
12. Hall W, Pacula RL (2003) Cannabis Use and Dependence. Public Health and Public Policy. Cambridge: Cambridge University Press.
13. MacCoun R, Reuter P (2001) Drug War Herisies Learning from Other Vices, Times and Places. Cambridge, UK: Cambridge University Press.
14. Rolles S (2009) After the war on drugs: Blueprint for regulations Bristol: Transform Drug Policy Foundation. Transform Drug Policy website. Available: http://www.tdpf.org.uk/ downloads/blueprint/Blueprint-exec-summary. pdf∧. Accessed 2010 January.
15. Hall W, Lynsky M (2009) The challenges in developing a rational cannabis policy. Current Opinion Psychiatry 22: 258-262.
16. Kilmer B, Caulkins J, Liccardo Pacula R, MacCoun R, Reuter P (2010) Altered State? Assessing how marijuan legalization in California could influence marijuana consumption and public markets. Santa Monica: RAND Drug Policy Research Centre. Available: http://www.rand.org/pubs/ occasional-papers/OP315. html∧. Accessed.
17. May T, Duffy M, Warburton H, Hough M (2007) Policing cannabis as a Class C drug, An arresting change? York: ICPR, School of Law, King's College.
18. May T, Warburton H, Turnbull P, Hough M (2002) Times they are a changing. York: Joseph Rountree Foundation.
19. Donnelly N, Hall W, Christie P (1999) Effects of the cannabis expiation notice scheme on levels and patterns of cannabis use in South Australia: evidence from the National Drug Strategy Household Surveys 1985-1995. Canberra: DoHA. No.37.
20. Williams J (2004) The effects of price and policy on marijuana use: what can be learned from the Australian experience? Health Economics 13: 123-137.
21. McCaffrey D, Pacula RL, Han B, Ellickson P (2010) Marijuana use and high school dropout: the influence of unobservables. Health Economics 19: 1281-1299.
22. van Ours J, Willams J (2009) Why parents worry: Initiation into cannabis use by youth and their educational attainment. Journal of Health Economics 28: 132-142.
23. Horwood L, Fergusson D, Hayatbakhshm M, Najman J, Coffey C, et al. (2010) Cannabis use and educational achievement: findings from three Australasian cohort studies. Drug and Alcohol Dependence 110: 247-253.
24. Mann RE, Adlaf E, Zhao J, Stoduto G, Ialomiteanu A, et al. (2007) Cannabis use and self-reported collisions in a representative sample of adult drivers. Journal of Safety Research 38: 669-674. (Pubitemid 350234760)
25. Laumon B, Gadegbeku B, Martin J, Biecheler M (2005) Cannabis intoxication and fatal road crashes in France: population based case-control study. British Journal of Medicine 331: 1371-1374. (Pubitemid 43773488)
26. Vining A, Weimer D (2010) An assessment of important issues concerning the application of benefit-cost analysis to social policy. Journal of Benefit-Cost Analyisis 1: 1-37.
27. Sindelar J, Jofre-Bonet M, French M, McLellan A (2004) Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes. Drug and Alcohol Dependence 73: 41-50. (Pubitemid 37542477)
28. Drummond M, Sculpher M, Torrance G, O'Brien B, Stoddart G (2005) Methods for the Economic Evaluation of Health Care Programmes, Third Edition. Oxford: Oxford Medical Publications.
29. Tsuchiya A, Williams A (2001) Welfare economics and economic evaluation. In: Drummond M, McGuire A, editors. Economic Evaluation in Health Care Merging Theory With Practice Oxford: Oxford University Press.
30. Mishan E, Quah E (2007) Cost benefit analysis, 5th Edition. Abingdon: Routledge.
31. Pudney S (2010) Drugs policy: what should we do about cannabis? Economic Policy 25: 165-211.
32. McIntosh E (2010) Introduction. In: McIntosh E, Clarke P, Frew E, Lourviere J, editors. Applied Methods of Cost-Benefit Analysis in Health Care. Oxford: Oxford University Press.
33. Ableson P (2000) Public Economics Principles and Practice. Sydney: Applied Economics.
34. NSW Police Force (2007) Cannabis Cautioning Scheme. NSW Government Website. Available: http://www.police.nsw.gov.au/community-issues/drugs/related- information/cannabis-cautioning-scheme. Accessed 2009 October.
35. NSW Police Force (2009) Thin Blue Line Information Section Young Offenders Act. Sydney: NSW Police Website. Available:http://www.policensw.com/ info/gen/y2.html. Accessed 2009 October.
36. Caulkins J, Kilmer B, MacCoun R, Pacula R, Reuter P (2011) Design considerations for legalizing cannabis: lessons inspired by analysis of California's Proposition 19. Addiction 107: 865-871.
37. Nadelmann E (1989) Drug Prohibition in the United States: Costs, consequences, and alternatives. Science 245: 939-947.
38. Haden M (2004) Regulation of illegal drugs: an exploration of public health tools. International Journal of Drug Policy 15: 225-230.
39. McDonald D, Moore R, Norberry J, Wardlaw G, Ballenden N, et al. (1994) Legislative options for cannabis in Australia. Canberra Commonwealth Department of Human Series and Health.
40. King County Bar Association (2005) Effective drug control: Toward a new legal framework. Seatle: King County Bar Association. King County Bar Association website. Available: https://www.kcba.org/druglaw/pdf/ EffectiveDrugControl.pdf. Accessed 2014 April 4.
41. Babor T, Caetano R, Casswell S, Edwards G, Giesbrecht N, et al. (2003) Alcohol: No Ordinary Commodity. Oxford: Oxford University Press.
42. Department of Justice (2009) Becoming a poppy grower. Hobart: Tasmanian Government. Available: http://www.justice.tas.gov.au/poppy/becoming-a-grower. Accessed 2009 August.
43. Godfrey C (2006) Evidenced based illicit drug policy: the potential contribution of economic evaluation techniques. De Economist 154: 563-580.
44. Trumbull W (1990) Who has standing in cost-benefit analysis. Journal of Policy Analysis and Management 9: 201-218.
45. Whittington D, MacRae D (1986) The issue of standing in cost-benefit analysis. The Journal of Policy Analysis and Management 5: 665-682.
46. Shanahan M (2011) Assessing the economic consequences of two cannabis policy options Sydney: New South Wales. 365 p.
47. Australian Government Productivity Commission (2007) Report on Government Services 2006 Court Administration. Canberra Available: http://www.pc.gov.au/- data/assets/pdf-file/0006/61674/chapter06.pdf. Accessed 2014 March.
48. Bureau of Crime Statistics and Research (2006) Court Statistics. Sydney: NSW Government Law Link. BOSCAR website, Available: http://www.bocsar.nsw.gov. au/lawlink/bocsar/ll-bocsar.nsf/pages/bocsar-court-stats.
49. Passey M, Patete S, Bird G, Bold S, Brooks L, et al. (2003) Evaluation of the Lismore MERIT Pilot Program Final Report. Lismore: Northern Rivers University Department of Rural Health. Available: http://www.ncahs.nsw.gov.au/ tmp/final-report-MERIT-evaluation.pdf∧. Accessed 2008.
50. Martire K, Larney S (2009) Principal drug of concern: An analysis of MERIT and RAD client characteristics and outcomes Sydney: Attorney General's Department, NSW Government. Available: http://www.lawlink.nsw.gov.au/lawlink/ cpd/merit.nsf/vwFiles/Issue-7-A4-Merit-Drug.pdf/$file/ Issue-7-A4-Merit-Drug.pdf∧6/03/2013. Accessed 2010 October.
51. Australian Bureau of Statistics (2006) Employee Earnings and Hours, Australia, May 2006 Canberra Australian Bureau of Statistics. ABS website. Available: http://www.abs.gov.au/ausstats/absat.nsf/Previousproducts/6306. 0Main%20Features2May%202006?opendocument&tabname=Summar&tabname= Summary&prodno=6306.0&issue=May%202006&num=&view=∧. Accessed 2009.
52. Shanahan M, Ritter A (2014) Intangible outcomes from a policy change: using contingent valuation to quantify potential stigma from a cannabis offence. Journal of Experimental Criminology. 10: 59-77.
53. Ngui R, Shanahan M (2010) Cannabis use disorder treatment and associated heath care costs: NSW 2007. Sydney: NDARC.UNSW Autralia. NDARC website. Available: http://www.dpmp.unsw.edu.au/DPMPWeb.nsf/resources/Monograph+16.pdf/ $file/DPMP+MONO+20.pdf∧.
54. Burns L, Mattick R, Cooke M (2006) The use of record linkage to examine illicit drug use in pregnancy. Addiction 101: 873-882. (Pubitemid 43727521)
55. English D, Hulse G, Milne E, Holman C, Bower C (1997) Maternal cannabis use and birth weight: a meta-analysis. Addiction 92: 1553-1560. (Pubitemid 27499566)
56. Fergusson D, Horwood L, Northstone K (2002) Maternal use of cannabis and pregnancy outcome. BJOG 109: 21-27.
57. Crancer A, Crancer A (2010) The Involvement of Marijuana in California Fatal Motor Vehicle Crashes 1998-2008. Available: http://druggeddriving.org/ pdfs/CAMJStudyJune2010.pdf. Accessed 2014 April 4.
58. Drummer O, Gerostamoulos J, Batziris H, Chu M, Caplehorn J, et al. (2004) The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accident Analysis and Prevention 36: 239-248.
59. Fergusson D, Horwood L (2001) Cannabis use and traffic accidents in a birth cohort of young adults. Accident Analysis & Prevention 33: 703-711. (Pubitemid 32798099)
60. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, et al. (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370: 319-328. (Pubitemid 47094993)
61. Australian Institute of Health and Welfare (2008) 2007 National Drug Strategy Household Survey. Detailed Findings Canberra: Australian Institute of Health and Welfare.2010 National Drug Strategy Household Survey report (AIHW)∧.
62. Carr V, Neil A, Halpin S, Holmes S, Lewin T (2003) Costs of schizophrenia and other psychoses in urban Australia: findings from the low prevalence (psychotic) disorders study. Australian New Zealand Journal of Psychiatry 37: 31-40. (Pubitemid 36395326)
63. Tolkien II Team (2006) Tolkien II. A needs-based, costed stepped care model for Mental Health Services. Darlinghurst, NSW, Australia: World Health Organisation Collaborating Centre for Classification in Mental Health.
64. Pudney S, Badillo C, Bryan M, Burton J, Conti G, et al. (2006) Estimating the size of the UK illicit drug market. In: Singleton N, Murray R, Tinsley T, editors. Measuring different aspects of problem drug use: methodological developments: Home Office Online Report. Available: http://www.homeoffice.gov. uk/publications/science-research-statistics/research-statistics/crime-research/ hoor1606. Accessed 2008 January.
65. Rhodes W, Langenbahn S, Kling R, Scheiman P (1997) What America's users spend on illegal drugs, 1988-1995. Rockville MD: Office of National Drug Control Policy.
66. Hickman M, Vickerman P, Macleod J, Lewis G, Zammit S, et al. (2010) If cannabis caused schizophrenia-how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations. Addiction 104 1856-1861.
67. Teesson M, Slade T, Swift W, Mills K, Memedovic S, et al. (2012) Prevalence, correlates and comorbidity of DSM-IV Cannabis Use Disorders in Australia: Findings of the 2007 National Survey of Mental Health and Wellbeing Australian & New Zealand Journal of Psychiatry 46: 1182-1192.
68. Mann RE, Stoduto G, MacDonald S, Brands B, editors (2008) Cannabis use and driving: implications for public health and transport policy. Lisbon: European Monitoring Centre for Drugs and Addiction (EMCDDA).
69. Pacula RL (2010) Examining the impact of Marijuana legalisation on harms associated with marijuana use. Santa Monica: Rand. RAND wsite. http://www.rand.org/pubs/working-papers/WR769.html. Accessed 2014 April.
70. Access Economics (2008) The health of nations: the value of a statistical life. Canberra: Australian Safety and Compensation Council. Safework Australia website. Available: http://www.safeworkaustralia.gov.au/AboutSafeWorkAustralia/ WhatWeDo/Publications/Documents/330/TheHealthOfNations-Value-StatisticalLife- 2008-PDF.pdf∧. Accessed 2014 April 4.
71. Leigh A, Ryan C (2008) Estimating returns to education using different natural experiment techniques. Economics of Education Review 27: 149-160.
72. Zarkin G, Cates S, Bala M (2000) Estimating the willingness to pay for drug abuse treatment: A pilot study Journal of Substance Abuse Treatment 18: 149-159. (Pubitemid 30123098)
73. French M, Salome H, Sindelar J, McLellan A (2002) Benefit-cost analysis of addiction treatment: methodological guidelines and empirical application using the DATCAP and ASI. Health Services Research 37: 433-455. (Pubitemid 34982573)
74. Weimer D, Vining A, Thomas R (2009) Cost-benefit analysis involving addictive goods: Contingent valuation to estimate willingness-to pay for smoking cessation. Health Economics 18: 181-202.
75. Boys A, Marsden J, Strang J (2001) Understanding reasons for drug use amongst young people: a functional perspective. Health Education Research 16: 457-469. (Pubitemid 32769161)
76. Phillips B, Burns L (2008) NSW Drug Trends 2008 Findings from the Illicit Drug Reporting System (IDRS) Sydney: NDARC, UNSW Australia. NDARC website Available: http://ndarc.med.unsw.edu.au/project/illicit-drug-reporting-system- idrs∧. Accessed 2009 February.
77. Roads and Traffic Authority (2010) Licensing. Sydney: NSW Government. NSW Government website. Available: http://www.rta.nsw.gov.au/licensing/. Accessed 2009 October.
78. California Department of Public Health (2010) Medical Marijuana Program Fees. State of California. Available: http://www.cdph.ca.gov/programs/MMP/Pages/ MMPFees.aspx. Accessed 2011 July.
79. Communities Office of Liquor Gaming and Racing (2010) Underage drinking offences. Sydney: New South Wales Government. Available: http://www.olgr.nsw. gov.au/youth-fines.asp. Accessed 2009 October.
80. Ministerial Council on Drug Strategy (2005) Australian National Tobacco Strategy 2004-2009: Guide to Planning and Investing in Tobacco Control. Canberra Available: http://www.health.gov.au/internet/main/publishing.nsf/Content/ E955EA2B5D178432CA256FD30017A522/$File/tobacco-planning.pdf∧. Accessed 2010 December 1.
81. Australian Institute of Health and Welfare (2008) 2007 National Drug Strategy Household Survey. First Results Canberra: Australian Institute of Health and Welfare. Available: www.aihw.gov.au/publication-detail/?id= 6442468084∧. Accessed 2008 November.
82. NSW Industrial Relations (2008) NSW public sector awards and agreements 2008. Sydney NSW Governement. NSW Industrial Relations (2008) NSW public sector awards and agreements 2008. Accessed 2008 July.
83. Australian Competition and Consumer Commission (2008) Report of the ACCC inquiry into the competitiveness of retail prices for standard groceries. Canberra: Australian Competition and Consumer Commission. http://transition. accc.gov.au/content/index.phtml?itemId=838251∧. Accessed 2010 January.
84. Geis G (2005) Chop-chop: The illegal cigarette market in Australia. Canberra: Centre for Tax System Integrity. Available: http://regnet.anu.edu.au/ sites/default/files/ROP2.pdf∧. Accessed 2008 March.
85. Cameron L, Williams J (2001) Cannabis, alcohol and cigarettes: substitutes or complements? The Economic Record 77: 19-34. (Pubitemid 32282147)
86. Williams J, Pacula RL, Chaloupka FJ, Wechsler H (2004) Alcohol and marijuana use among college students: economic compliments or substitutes. Health Economics 133: 825-843. (Pubitemid 39264231)
87. MacCoun R (2010) Estimating the non-price effects of legalization on cannabis consumption. Santa Monica: RAND. RAND website. Available: http://www.rand.org/pubs/working-papers/WR767.html∧. Accessed 2014 April 4.
88. Weatherburn D, Jones C, Donnelly N (2003) Prohibition and Cannabis Use in Australia: A Survey of 18- to 29-year-olds. The Australian and New Zealand Journal of Criminology 36: 77-93. (Pubitemid 36814541)
89. Wood E, Werb D, Fischer B, Hart C, Wodak A, et al. (2010) Tools for debate: US Federal Government data on cannabis prohibition. Vancouver: International Centre for Science in Drug Policy. International Centre for Science in Drug Policy website. Available: http://www.icsdp.org/research/ publications/toolsfordebate.aspx∧6/03/2013. Accessed 2011 January.
90. Callard C, Thompson D, Collishaw N (2005) Transforming the tobacco market: why the supply of cigarettes should be transferred from for-profit corporations to non-profit enterprises with a public health mandate Tobacco Control 14: 278-283. (Pubitemid 41128904)
91. World Health Organization (2005) WHO Framework Convention on Tobacco Control. Geneva, Switzerland: WHO Document Production Services. Available: http://www.who.int/tobacco/framework/WHO-FCTC-english.pdf∧. Accessed 2010 September.
92. Freeman B, Chapman S, Rimmer M (2008) The case for plain packaging of tobacco products. Addiction 103: 580-590. (Pubitemid 351389284)
93. Cancer Council Victoria (2010) Tobacco in Australia: facts and issues a comprehensive online resource. Melbourne. Tobacco in Australia website Available: http://www.tobaccoinaustralia.org.au/chapter-11-advertising/11-3- federal-legislation∧. 2010 Accessed November.